… that SARS-CoV-2 directed T-cell immunotherapy targeting … for the prevention or early
treatment of SARS-CoV-2 infection in … , including the novel discovery that SARS-CoV-2–specific T …

… Immunotherapeutic strategies Here, we focus on promising immunotherapies that increase
immunity against SARS-CoV-… The application of immunotherapeutic drugs that mostly act as …

… ABT passive immunotherapy is based on nAbs to keep pathogens from entering the host
cell… the fastest discovery of ABT for SARS-CoV and SARS-CoV-2 in science history [43]. …

… Extensive sequence analysis of the antibody epitope to SARS CoV-2 Wuhan variant
revealed a conserved epitope in all SARS CoV-2 variants including Beta, Gamma, and most …

In this hypothesis, we address the biological/immunological pathway leading to severe
disease or death after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV…

… to recognize and kill SARS-CoV-2 target cells. We report here several SARS-CoV-2 epitopes
… The antigen discovery platform for SARS-CoV-2 comprises four steps: 1) peptide elution …

… The amino acid mutations in the RBD from SARS-classic to SARS-CoV-2 include the … in
SARS-CoV-2 than SARS-CoV [22]. Moreover, several residue changes in the SARS-CoV-2 RBD …

… cellular and humoral immune changes induced by SARS-CoV-2 and to propose the possibility
… the immunotherapeutic approach is of fundamental importance for SARS-CoV-2 infection. …

… Since the discovery of the causative agent of SARS, the SARS-CoV, sequencing of its …
Among the efforts, developing immunotherapy such as neutralizing monoclonal antibodies and …

… SARS CoV, Middle East respiratory syndrome related coronavirus (MERS CoV), and other
coronavirus vaccines revealed several safety concerns associated with the use of coronavirus …